当前位置:
X-MOL 学术
›
Nat. Rev. Clin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
CAR T cells show promise in the frontline for high-risk LBCL.
Nature Reviews Clinical Oncology ( IF 78.8 ) Pub Date : 2022-05-01 , DOI: 10.1038/s41571-022-00628-y David Killock 1
中文翻译:
CAR T 细胞在高风险 LBCL 的前线显示出前景。
更新日期:2022-03-31
Nature Reviews Clinical Oncology ( IF 78.8 ) Pub Date : 2022-05-01 , DOI: 10.1038/s41571-022-00628-y David Killock 1
Affiliation
中文翻译:
CAR T 细胞在高风险 LBCL 的前线显示出前景。